纵横研报
Ticker Detail

688298.SHG

¥20.52+2.81% 东方生物 Medical Devices
00Reports China 医疗健康
Zhejiang Orient Gene Biotech Co Ltd
医疗健康 · 医疗器械

Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagnosis; and quantum-beads multiplex. Zhejiang Orient Gene Biotech Co., Ltd was founded in 2005 and is based in Huzhou, China.

MARKET 市值 3.89B CNY 52W ¥17.03 – ¥30.65 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 33.5% ROE -9.1% 营业利润率 -29.0% 净利润率 -54.6%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制